Teva Carries Israel and Biotech ETFs (RealMoney.com $)
Those looking to play Teva's attempt to enter the U.S. biogenerics market should consider EIS.
09:46AM 12/02/09
Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz
Stocks will move if any of these unexpected events come true.
11:16AM 11/30/09
Waiting for Oversold Conditions (Top Stocks $)
Investors should be wary of delving into the market until this development occurs.
08:32AM 11/27/09
The market will be tough to gauge until it reaches a solid oversold reading next week.
07:04PM 11/24/09
Narrower and Narrower (Top Stocks $)
The past few rallies have been successively taking fewer and fewer individual stocks along for the ride.
07:21PM 11/23/09
It's a Coin Toss (Top Stocks $)
The market could just as easily go up or down this week.
08:04AM 11/23/09
Don't Get Too Excited (Top Stocks $)
The market took a fall, but it still hasn't registered an oversold reading.
08:35PM 11/19/09
Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09
Familiar Patterns (Top Stocks $)
As we've learned recently, the types of statistics we're currently seeing tend to set up for a decent oversold rally.
08:48PM 11/18/09
'Mad Money' Recap: Cash for Caulkers
Cramer tells investors which trades would work on an intriguing stimulus program that would reward people for weatherizing their homes.
06:42PM 11/18/09
Wallop in the Cards (Top Stocks $)
After all, the market is overbought, we are continuing to see divergences, and it's options-expiration week.
08:12PM 11/17/09
Is It Really About the Dollar? (RealMoney.com $)
Don't get wrapped up in the weak-dollar hoopla -- It's only a part of the story.
07:04AM 11/17/09
Keep an Eye on the Dollar (Top Stocks $)
A number of technical developments in the greenback warrant some scrutiny.
07:29PM 11/16/09
Dying to Short? (Top Stocks $)
Both on a statistical and an anecdotal basis, investors seem not to trust this rally.
07:27PM 11/11/09
Blood Cancer Meeting Abstracts Released: BioBuzz
No data in Celgene abstract, disappointing investors.
12:16PM 11/10/09
Connect with TheStreet